GNTLF - Genetic Technologies Limited (GENE) Acting CEO George Muchnicki on Quarterly Investor Webinar Transcript
Genetic Technologies Limited (GENE) Quarterly Investor Webinar January 27, 2021 07:30 PM ET Company Participants Stephanie Ottens - Investor Relations George Muchnicki - Acting Chief Executive Officer Peter Rubinstein - Chairman Richard Allman - Chief Scientific Officer Conference Call Participants Presentation Stephanie Ottens Good morning and welcome everyone to Genetic Technologies Quarterly Investor Webinar. And we have the pleasure this morning to have from Genetic, Dr. George Muchnicki, Acting CEO on the results and progress over the quarter. This will be followed by an opportunity for investors' questions following the presentation. We'll be joined by the Chairman of Genetic Technologies, Peter Rubinstein and Chief Scientific Officer, Richard Allman. Please submit all of your questions via the Q&A function, and we will endeavor to keep the session for about 45 minutes. So, I'll now hand it over to George to take us through the presentation. George Muchnicki Thank you, Stephanie, and
For further details see:
Genetic Technologies Limited (GENE) Acting CEO George Muchnicki on Quarterly Investor Webinar Transcript